Immune response in SARS-CoV-2 infection: the role of interferons type I and type III
- PMID: 32866437
- PMCID: PMC7448817
- DOI: 10.1016/j.bjid.2020.07.011
Immune response in SARS-CoV-2 infection: the role of interferons type I and type III
Abstract
Background: There is scarce information on the human immune response to the SARS-CoV-2 infection, and on the exacerbated inflammatory reaction observed in severe COVID-19 cases.
Objective: To review the available evidence on the role of interferons type I and type III to SARS-CoV-2 infection.
Methods: We reviewed the available published evidence on the role of immune response to SARS-CoV-2 infection as well as recent publications on characteristics and outcomes of COVID-19, and their relationship with interferons type I and type III.
Results: The available data indicates that immune response plays an important role in controlling SARS-CoV-2 infection and the immune dysregulation can significantly modify the clinical outcomes of affected patients. In addition, the evidence suggests that IFN type I and III can play an important role in controlling viremia and modulating the immune response in COVID-19.
Conclusions: Due to their central role in immune response against SARS-CoV-2 infection, IFN type I and III could be considered for treatment of COVID-19.
Keywords: IFN type I; IFN type III; Immune response; SARS-CoV-2.
Copyright © 2020 Sociedade Brasileira de Infectologia. Published by Elsevier España, S.L.U. All rights reserved.
Similar articles
-
A role for retinoids in the treatment of COVID-19?Clin Exp Pharmacol Physiol. 2020 Oct;47(10):1765-1767. doi: 10.1111/1440-1681.13354. Epub 2020 Jun 11. Clin Exp Pharmacol Physiol. 2020. PMID: 32459003 Review.
-
Type 1 interferons as a potential treatment against COVID-19.Antiviral Res. 2020 Jun;178:104791. doi: 10.1016/j.antiviral.2020.104791. Epub 2020 Apr 7. Antiviral Res. 2020. PMID: 32275914 Free PMC article.
-
Protein Coding and Long Noncoding RNA (lncRNA) Transcriptional Landscape in SARS-CoV-2 Infected Bronchial Epithelial Cells Highlight a Role for Interferon and Inflammatory Response.Genes (Basel). 2020 Jul 7;11(7):760. doi: 10.3390/genes11070760. Genes (Basel). 2020. PMID: 32646047 Free PMC article.
-
SARS-CoV-2 viremia may predict rapid deterioration of COVID-19 patients.Braz J Infect Dis. 2020 Nov-Dec;24(6):565-569. doi: 10.1016/j.bjid.2020.08.010. Epub 2020 Sep 15. Braz J Infect Dis. 2020. PMID: 32950458 Free PMC article.
-
Potential Inhibitors for SARS-CoV-2 and Functional Food Components as Nutritional Supplement for COVID-19: A Review.Plant Foods Hum Nutr. 2020 Dec;75(4):458-466. doi: 10.1007/s11130-020-00861-9. Epub 2020 Oct 10. Plant Foods Hum Nutr. 2020. PMID: 33037564 Free PMC article. Review.
Cited by
-
MyD88 and beyond: a perspective on MyD88-targeted therapeutic approach for modulation of host immunity.Immunol Res. 2021 Apr;69(2):117-128. doi: 10.1007/s12026-021-09188-2. Epub 2021 Apr 8. Immunol Res. 2021. PMID: 33834387 Free PMC article. Review.
-
Immunological dysfunction persists for 8 months following initial mild-to-moderate SARS-CoV-2 infection.Nat Immunol. 2022 Feb;23(2):210-216. doi: 10.1038/s41590-021-01113-x. Epub 2022 Jan 13. Nat Immunol. 2022. PMID: 35027728
-
A comprehensive review about immune responses and exhaustion during coronavirus disease (COVID-19).Cell Commun Signal. 2022 Jun 2;20(1):79. doi: 10.1186/s12964-022-00856-w. Cell Commun Signal. 2022. PMID: 35655192 Free PMC article. Review.
-
An overview on nanoparticle-based strategies to fight viral infections with a focus on COVID-19.J Nanobiotechnology. 2022 Oct 8;20(1):440. doi: 10.1186/s12951-022-01625-0. J Nanobiotechnology. 2022. PMID: 36209089 Free PMC article. Review.
-
Antibody-Based Immunotherapeutic Strategies for COVID-19.Pathogens. 2020 Nov 5;9(11):917. doi: 10.3390/pathogens9110917. Pathogens. 2020. PMID: 33167401 Free PMC article. Review.
References
-
- World Health Organization. Novel Coronavirus (2019‐nCoV) situation report‐2 [published online ahead of print January 21, 2020]. https://www.who.int/docs/default‐source/coronaviruse/situationreports/20....
-
- World Health Organization. Novel coronavirus – China. Jan 12, 2020. http://www.who.int/csr/don/12-january-2020-novel-coronavirus-china/en/ (accessed Jan 19, 2020).
-
- Zaki A.M., van Boheemen S., Bestebroer T.M., Osterhaus A.D., Fouchier R.A. Isolation of a novel coronavirus from a man with pneumonia in Saudi Arabia. N Engl J Med. 2012;367:1814–1820. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Miscellaneous